Javascript must be enabled to continue!
Safe Handling of Cytotoxics: Guideline Recommendations
View through CrossRef
Background: This evidence-based practice guideline was developed to update and address new issues in the handling of cytotoxics, including the use of oral cytotoxics; the selection and use of personal protective equipment; and treatment in diverse settings, including the home setting. Methods: The guideline was developed primarily from an adaptation and endorsement of an existing guideline and from three systematic reviews. Before publication, the guideline underwent a series of peer and external reviews to gather feedback. All comments were addressed, and the guideline was amended when required. The guideline applies to health care workers who could come into contact with cytotoxic drugs at any point in the medication circuit. The intended users are hospital administrators, educators, and managers; occupational health and safety services; and pharmacy and health care workers. Results: The recommendations represent a reasonable and practical set of procedures that the intended users of this guideline should implement to minimize opportunities for accidental exposure. They are not limited to just the point of care; they cover the entire chain of cytotoxics handling from the time such agents enter the institution until they leave in the patient or as waste. Conclusions: Reducing the likelihood of accidental exposure to cytotoxic agents within the medication circuit is the main objective of this evidenced-based guideline. The recommendations differ slightly from earlier guidelines because of the availability of new evidence.
Title: Safe Handling of Cytotoxics: Guideline Recommendations
Description:
Background: This evidence-based practice guideline was developed to update and address new issues in the handling of cytotoxics, including the use of oral cytotoxics; the selection and use of personal protective equipment; and treatment in diverse settings, including the home setting.
Methods: The guideline was developed primarily from an adaptation and endorsement of an existing guideline and from three systematic reviews.
Before publication, the guideline underwent a series of peer and external reviews to gather feedback.
All comments were addressed, and the guideline was amended when required.
The guideline applies to health care workers who could come into contact with cytotoxic drugs at any point in the medication circuit.
The intended users are hospital administrators, educators, and managers; occupational health and safety services; and pharmacy and health care workers.
Results: The recommendations represent a reasonable and practical set of procedures that the intended users of this guideline should implement to minimize opportunities for accidental exposure.
They are not limited to just the point of care; they cover the entire chain of cytotoxics handling from the time such agents enter the institution until they leave in the patient or as waste.
Conclusions: Reducing the likelihood of accidental exposure to cytotoxic agents within the medication circuit is the main objective of this evidenced-based guideline.
The recommendations differ slightly from earlier guidelines because of the availability of new evidence.
Related Results
Overcoming immuno-resistance by rescheduling anti-VEGF/cytotoxics/anti-PD-1 combination in lung cancer model
Overcoming immuno-resistance by rescheduling anti-VEGF/cytotoxics/anti-PD-1 combination in lung cancer model
Background: Many tumors are refractory to immune checkpoint inhibitors, but their combination with cytotoxics is expected to improve sensitivity. Understanding how and when cytoto...
Abstract 1566: Guideline-concordant care among women with HER2 negative metastatic breast cancer: A SEER-Medicare analysis
Abstract 1566: Guideline-concordant care among women with HER2 negative metastatic breast cancer: A SEER-Medicare analysis
Abstract
Objectives: Limited data exist regarding the rates of guideline-concordant care among women with HER2 negative metastatic breast cancer (MBC). The primar...
Abstract 2099: Model-riven optimization of anti-angiogenics combined with chemotherapy: application to bevacizumab + pemetrexed/cisplatin doublet in NSCLC-bearing mice
Abstract 2099: Model-riven optimization of anti-angiogenics combined with chemotherapy: application to bevacizumab + pemetrexed/cisplatin doublet in NSCLC-bearing mice
Abstract
Bevacizumab-containing protocols are all based upon the concomitant administration of the drugs given in a row. Bevacizumab is expected to induce a transien...
Addressing HIV-related stigma and discrimination in healthcare settings: development and contextualization of guideline recommendations
Addressing HIV-related stigma and discrimination in healthcare settings: development and contextualization of guideline recommendations
Abstract
Objective
This objective of this project was to develop and contextualize guideline recommendations to reduce HIV-related stigma and discrimination (SAD) in Ethiop...
U.K. National Clinical Guidelines in Paediatric Dentistry
U.K. National Clinical Guidelines in Paediatric Dentistry
In 1994 the Department of Health requested the Royal College of Surgeons to produce National Clinical Guidelines. This task was delegated to the Paediatric Dentistry Clinical Audit...
Modeling Guidelines for Integration into Clinical Workflow
Modeling Guidelines for Integration into Clinical Workflow
The success of clinical decision-support systems requires that they are seamlessly integrated into clinical workflow. In the SAGE project, which aims to create the technological in...
Interview: Kari Tikkinen
Interview: Kari Tikkinen
What initially sparked your interest in medicine, and what led you specifically to the field of urology?
I was not sure about medicine until I was almost 20. In high school I was t...
[RETRACTED] Keanu Reeves CBD Gummies v1
[RETRACTED] Keanu Reeves CBD Gummies v1
[RETRACTED]Keanu Reeves CBD Gummies ==❱❱ Huge Discounts:[HURRY UP ] Absolute Keanu Reeves CBD Gummies (Available)Order Online Only!! ❰❰= https://www.facebook.com/Keanu-Reeves-CBD-G...

